由构成性活性STING诱导的组织炎症是由增强的TNF信号传递介导的
Hella Luksch1, Felix Schulze1, David Geißler-Lösch2
1Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
eLife
|March 20, 2025
概括
瘤亡因子受体 (TNFR) 信号驱动小鼠在婴儿期 (SAVI) 发病的STING相关血管病变. 阻止TNFR1和TNFR2改善了SAVI症状,这表明TNFR抗体可以治疗患者.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 自燃性炎症疾病 自燃性炎症疾病
背景情况:
- 在STING中获得功能突变导致构成性激活,导致在婴儿期发病的STING相关血管病变 (SAVI).
- SAVI的特征是T细胞淋巴衰竭,炎症性肺病和神经退行.
- 瘤亡因子 (TNF) 信号在SAVI病变发生中的作用尚未完全理解.
研究的目的:
- 研究TNF受体 (TNFR) 信号传导在SAVI病变发生过程中的作用.
- 为了确定TNFR1和TNFR2的遗传失活化是否会影响小鼠模型中的SAVI表现.
主要方法:
- 使用了SAVI的小鼠模型.
- 在SAVI小鼠中的基因失活的TNF受体1和2 (TNFR1和TNFR2).
- 评估T细胞种群,肺部病理,神经退行,细胞因子/化学因子转录和中性粒细胞迁移.
主要成果:
- 在SAVI小鼠中,TNFR1和TNFR2的遗传失活化挽救了胸细胞损失,减少了肺部疾病,并改善了神经退行.
- 阻断TNFR1和TNFR2会削弱由慢性STING激活驱动的促炎性细胞因子,化学因子和粘附蛋白的转录.
- 增加中性粒细胞的超内皮移动,这是炎症的标志,显著减少.
结论:
- 在小鼠模型中,TNFR信号传递在SAVI的发病过程中起着关键作用.
- 对TNFR1和TNFR2的遗传失活化有效地改善了关键的SAVI病理.
- 这些发现表明,现有的TNFR抗剂可能是SAVI患者的潜在治疗策略.
相关概念视频
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Inflammation
52.1K
Overview
52.1K
T Cell Types and Functions
730
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
730
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K


